Literature DB >> 16148165

The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench.

Melanie C Bacon1, Viktor von Wyl, Christine Alden, Gerald Sharp, Esther Robison, Nancy Hessol, Stephen Gange, Yvonne Barranday, Susan Holman, Kathleen Weber, Mary A Young.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16148165      PMCID： PMC1235804          DOI： 10.1128/CDLI.12.9.1013-1019.2005

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  23 in total

1.  Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women.

Authors:  Jessica E Justman; Lorie Benning; Ann Danoff; Howard Minkoff; Alexandra Levine; Ruth M Greenblatt; Kathleen Weber; Eva Piessens; Esther Robison; Kathryn Anastos
Journal:  J Acquir Immune Defic Syndr       Date:  2003-03-01       Impact factor: 3.731

2.  Prevalence and correlates of highly active antiretroviral therapy switching in the Women's Interagency HIV Study.

Authors:  Lynn M Kirstein; Ruth M Greenblatt; Kathryn Anastos; Alexandra Levine; Audrey L French; Howard Minkoff; Sylvia Silver; Stephen J Gange
Journal:  J Acquir Immune Defic Syndr       Date:  2002-04-15       Impact factor: 3.731

3.  Retention of women enrolled in a prospective study of human immunodeficiency virus infection: impact of race, unstable housing, and use of human immunodeficiency virus therapy.

Authors:  N A Hessol; M Schneider; R M Greenblatt; M Bacon; Y Barranday; S Holman; E Robison; C Williams; M Cohen; K Weber
Journal:  Am J Epidemiol       Date:  2001-09-15       Impact factor: 4.897

4.  Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1--infected women.

Authors:  Kimberly Battle-Miller; Christian A Eby; Alan L Landay; Mardge H Cohen; Beverly E Sha; Linda L Baum
Journal:  J Infect Dis       Date:  2002-01-31       Impact factor: 5.226

5.  Use of highly active antiretroviral therapy in a cohort of HIV-seropositive women.

Authors:  Judith A Cook; Mardge H Cohen; Dennis Grey; Lynn Kirstein; Jane Burke; Kathryn Anastos; Herminia Palacio; Jean Richardson; Tracey E Wilson; Mary Young
Journal:  Am J Public Health       Date:  2002-01       Impact factor: 9.308

6.  Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols.

Authors:  Monica Gandhi; Niloufar Ameli; Peter Bacchetti; Gerald B Sharp; Audrey L French; Mary Young; Stephen J Gange; Kathryn Anastos; Susan Holman; Alexandra Levine; Ruth M Greenblatt
Journal:  AIDS       Date:  2005-11-04       Impact factor: 4.177

7.  CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women.

Authors:  Sean Philpott; Barbara Weiser; Patrick Tarwater; Sten H Vermund; Cynthia A Kleeberger; Stephen J Gange; Kathryn Anastos; Mardge Cohen; Ruth M Greenblatt; Andrea Kovacs; Howard Minkoff; Mary A Young; Paolo Miotti; Michelle Dupuis; Chih-Hsiung Chen; Harold Burger
Journal:  J Infect Dis       Date:  2003-01-29       Impact factor: 5.226

8.  Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease.

Authors:  Kathryn Anastos; Yolanda Barrón; Paolo Miotti; Barbara Weiser; Mary Young; Nancy Hessol; Ruth M Greenblatt; Mardge Cohen; Michael Augenbraun; Alexandra Levine; Alvaro Muñoz
Journal:  Arch Intern Med       Date:  2002-09-23

9.  Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugs.

Authors:  Alan Landay; Lorie Benning; James Bremer; Barbara Weiser; Harold Burger; Marek Nowicki; Andrea Kovacs
Journal:  J Infect Dis       Date:  2003-07-01       Impact factor: 5.226

10.  Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.

Authors:  Raphael P Viscidi; Linda Ahdieh-Grant; Barbara Clayman; Kelly Fox; Leslie S Massad; Susan Cu-Uvin; Keerti V Shah; Kathryn M Anastos; Kathleen E Squires; Ann Duerr; Denise J Jamieson; Robert D Burk; Robert S Klein; Howard Minkoff; Joel Palefsky; Howard Strickler; Paula Schuman; Eva Piessens; Paolo Miotti
Journal:  J Infect Dis       Date:  2003-01-06       Impact factor: 5.226
View more
  413 in total

1.  Genital warts and vulvar intraepithelial neoplasia: natural history and effects of treatment and human immunodeficiency virus infection.

Authors:  L Stewart Massad; Xianhong Xie; Teresa Darragh; Howard Minkoff; Alexandra M Levine; D Heather Watts; Rodney L Wright; Gypsyamber D'Souza; Christine Colie; Howard D Strickler
Journal:  Obstet Gynecol       Date:  2011-10       Impact factor: 7.661

2.  Association between human immunodeficiency virus infection and stiffness of the common carotid artery.

Authors:  Eric C Seaberg; Lorie Benning; A Richey Sharrett; Jason M Lazar; Howard N Hodis; Wendy J Mack; Mark J Siedner; John P Phair; Lawrence A Kingsley; Robert C Kaplan
Journal:  Stroke       Date:  2010-08-26       Impact factor: 7.914

3.  Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women.

Authors:  David B Hanna; Nancy A Hessol; Elizabeth T Golub; Jennifer M Cocohoba; Mardge H Cohen; Alexandra M Levine; Tracey E Wilson; Mary Young; Kathryn Anastos; Robert C Kaplan
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-15       Impact factor: 3.731

4.  HIV RNA levels in plasma and cervical-vaginal lavage fluid in elite controllers and HAART recipients.

Authors:  Alan Landay; Elizabeth T Golub; Seema Desai; Jinbing Zhang; Val Winkelman; Kathryn Anastos; Helen Durkin; Mary Young; Maria C Villacres; Ruth M Greenblatt; Philip J Norris; Michael P Busch
Journal:  AIDS       Date:  2014-03-13       Impact factor: 4.177

5.  Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women.

Authors:  Judith I Tsui; Audrey L French; Eric C Seaberg; Michael Augenbraun; Marek Nowicki; Marion Peters; Phyllis C Tien
Journal:  Clin Infect Dis       Date:  2007-08-10       Impact factor: 9.079

6.  Obesity and immune cell counts in women.

Authors:  Julie Womack; Phyllis C Tien; Joseph Feldman; Ja Hyun Shin; Kristopher Fennie; Kathryn Anastos; Mardge H Cohen; Melanie C Bacon; Howard Minkoff
Journal:  Metabolism       Date:  2007-07       Impact factor: 8.694

7.  Perceptions of intersectional stigma among diverse women living with HIV in the United States.

Authors:  Whitney S Rice; Carmen H Logie; Tessa M Napoles; Melonie Walcott; Abigail W Batchelder; Mirjam-Colette Kempf; Gina M Wingood; Deborah J Konkle-Parker; Bulent Turan; Tracey E Wilson; Mallory O Johnson; Sheri D Weiser; Janet M Turan
Journal:  Soc Sci Med       Date:  2018-05-04       Impact factor: 4.634

8.  Colonization by Candida species of the oral and vaginal mucosa in HIV-infected and noninfected women.

Authors:  Daniel Merenstein; Haihong Hu; Cuiwei Wang; Pilar Hamilton; Mandy Blackmon; Hui Chen; Richard Calderone; Dongmei Li
Journal:  AIDS Res Hum Retroviruses       Date:  2012-11-19       Impact factor: 2.205

9.  Pilot Study of Markers for High-grade Anal Dysplasia in a Southern Cohort From the Women's Interagency Human Immunodeficiency Virus Study.

Authors:  Cecile D Lahiri; Minh Ly Nguyen; C Christina Mehta; Marina Mosunjac; Talaat Tadros; Elizabeth R Unger; Mangalathu S Rajeevan; Jendai Richards; Ighovwerha Ofotokun; Lisa Flowers
Journal:  Clin Infect Dis       Date:  2020-03-03       Impact factor: 9.079

10.  The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States.

Authors:  Yuehan Zhang; Tracey E Wilson; Adebola Adedimeji; Daniel Merenstein; Joel Milam; Jennifer Cohen; Mardge Cohen; Elizabeth T Golub
Journal:  AIDS Behav       Date:  2018-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.